Literature DB >> 15060753

Is 11C-choline the most appropriate tracer for prostate cancer? For.

Ferruccio Fazio1, Maria Picchio, Cristina Messa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15060753     DOI： 10.1007/s00259-004-1542-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  29 in total

Review 1.  PET imaging of prostate cancer with 11C-acetate.

Authors:  Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss
Journal:  J Nucl Med       Date:  2003-04       Impact factor: 10.057

2.  Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography.

Authors:  A Roivainen; S Forsback; T Grönroos; P Lehikoinen; M Kähkönen; E Sutinen; H Minn
Journal:  Eur J Nucl Med       Date:  2000-01

3.  Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.

Authors:  M Picchio; C Landoni; C Messa; L Gianolli; M Matarrese; F De Cobelli; A Del Maschio; F Fazio
Journal:  AJR Am J Roentgenol       Date:  2002-08       Impact factor: 3.959

Review 4.  Carcinoma of the prostate.

Authors:  R F Gittes
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

5.  Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

Authors:  Igle J de Jong; Jan Pruim; Philip H Elsinga; Willem Vaalburg; Han J Mensink
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

Review 6.  Radiologic diagnosis of bone metastases.

Authors:  D I Rosenthal
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

7.  Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.

Authors:  C Hofer; C Laubenbacher; T Block; J Breul; R Hartung; M Schwaiger
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

8.  Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.

Authors:  Cherry T Thomas; Patrick T Bradshaw; Brad H Pollock; James E Montie; Jeremy M G Taylor; Howard D Thames; Patrick W McLaughlin; David A DeBiose; David H Hussey; Richard L Wahl
Journal:  J Clin Oncol       Date:  2003-05-01       Impact factor: 44.544

9.  Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases.

Authors:  Friedhelm Wawroschek; Harry Vogt; Hermann Wengenmair; Dorothea Weckermann; Michael Hamm; Mathias Keil; Gerhard Graf; Peter Heidenreich; Rolf Harzmann
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

10.  11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.

Authors:  I J de Jong; J Pruim; P H Elsinga; W Vaalburg; H J A Mensink
Journal:  Eur Urol       Date:  2003-07       Impact factor: 20.096
View more
  3 in total

1.  Planar and SPECT imaging in the era of PET and PET-CT: can it survive the test of time?

Authors:  Abass Alavi; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

Review 2.  Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.

Authors:  Mark P S Dunphy; Jason S Lewis
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

Review 3.  Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Authors:  Valeria Panebianco; Flavio Barchetti; Daniela Musio; Francesca De Felice; Camilla Proietti; Elena Lucia Indino; Valentina Megna; Orazio Schillaci; Carlo Catalano; Vincenzo Tombolini
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.